Drug · DIN 02434334
OTEZLA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 18, 2021; first marketed December 1, 2014.
- Drug Identification Number (DIN)
- 02434334
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Apremilast L04AA32
- Class
- Human
- Record last updated
- May 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| APREMILAST | 30 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 29, 2020: NOC 23153New Drug Submission (NDS) · Change in product ownership
- November 12, 2014: NOC 16279New Drug Submission (NDS)
Other DINs named OTEZLA
- DIN 02434318 · Marketed